By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile

 

NPS Pharmaceuticals, Inc. 

Corporate Headquarters
550 Hills Drive, 3rd Floor
Bedminster  New Jersey  07921  U.S.A.
Phone: 908-450-5300 Fax: 908-450-5351


SEARCH JOBS


Industry
Biotechnology






Company News
Shire Comments On Press Release From FDA Regarding NPS Pharmaceuticals, Inc. (NPSP) Approval Of NATPARA® (Parathyroid Hormone) 1/26/2015 9:07:22 AM
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Natpara® (Parathyroid Hormone) For Injection As An Adjunct To Calcium And Vitamin D To Control Hypocalcemia In Patients With Hypoparathyroidism 1/26/2015 6:21:00 AM
Shire (SHPGY)'s $5.2 Billion Bet Pays Off as NPS Pharmaceuticals, Inc. (NPSP)'s Natpara Wins Approval 1/26/2015 6:16:44 AM
Shire (SHPGY) Officially Snaps Up NPS Pharmaceuticals, Inc. (NPSP) in $5.2 Billion Deal 1/11/2015 1:46:43 PM
NPS Pharmaceuticals, Inc. (NPSP) To Present At J.P. Morgan Healthcare Conference 1/6/2015 2:34:44 PM
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/18/2014 5:52:29 AM
NPS Pharmaceuticals, Inc. (NPSP) To Present At Oppenheimer Healthcare Conference 12/4/2014 2:58:56 PM
NPS Pharmaceuticals, Inc. (NPSP) Release: European Medicines Agency Validates Marketing Authorization Application For Natpar® (Parathyroid Hormone (rDNA)) In Hypoparathyroidism 12/2/2014 9:43:20 AM
NPS Pharmaceuticals, Inc. (NPSP) To Present At Deutsche Bank (DB) BioFEST Conference 11/26/2014 8:45:18 AM
NPS Pharmaceuticals, Inc. (NPSP) Release: Teduglutide Granted Orphan Drug Designation In Japan 11/24/2014 9:30:53 AM
12345678910...
//-->